Condition: Bone Tumor · Osteoporosis · Traumatic Fracture · Sponsor: Precision IO Group
The goal of this investigational device exemption is to evaluate the Epione assistance for introducer placement during percutaneous procedures in musculo-skeletic (MSK) structures of the pelvis and the spine in adults. The main question is the determination of the rate of feasible procedures assisted by the Epione device Participants will undergo their procedure(s) as planned by their physician. If they accept to participate to the study, the differences with standard of care will be: * The use of the Epione device to place the introducer(s), instead of freehand placement if they do not participate * Additional CT or CBCT scans during the procedure.
This description comes directly from the study's public registry record.
Erin Meyers · 305 731-2901 · clinical.department@quantumsurgical.com
Marion Chassouant · 448 19 40 50 · clinical.department@quantumsurgical.com
Always discuss trial participation with your own doctor first.
| UC San Diego | San Diego, California, United States | Recruiting |
| Baptist Hospital Of Miami, Inc | Miami, Florida, United States | Recruiting |
| Rush University Medical Center | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07325578